Laser capture microdissection with genome-wide expression profiling displayed gene expression signatures in endometrioid endometrial cancer

Cancer Investigation

Volumn 30, Issue 2, 2012, Pages 156-164

  Mokhtar, Norfilza Mohd ^a,b   Ramzi, Nurul Hanis ^a   Yin Ling, Wong ^b   Rose, Isa Mohamed ^b   Hatta Mohd Dali, Ahmad Zailani ^b   Jamal, Rahman ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^b DEPARTMENT OF PHARMACOLOGY   (Malaysia)

Author keywords

Endometrioid endometrial cancer; Gene expression; Genomics; Laser capture microdissection; Microarray technology

Indexed keywords

ADULT; AGED; AMINO ACID TRANSPORT; ARTICLE; CARCINOGENESIS; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; GENE; GENE EXPRESSION PROFILING; H19 GENE; HUMAN; HUMAN TISSUE; LASER CAPTURE MICRODISSECTION; MICROARRAY ANALYSIS; PATHOGENESIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA TRANSLATION; SATB1 GENE; SLC7A5 GENE; ZAK GENE;

CARCINOMA, ENDOMETRIOID; DOWN-REGULATION; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; HUMANS; INCIDENCE; LASER CAPTURE MICRODISSECTION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 84856098101     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2011.633290     Document Type: Article

References (31)

1. Haidopoulos D, Simou M, Akrivos N, Rodolakis A, Vlachos G, Fotiou S, Sotiropoulou M, Thomakos N, Biliatis I, Protopappas A, Antsaklis A. Risk factors in women 40 years of age and younger with endometrial carcinoma. Acta Obstet Gynecol Scand 2010;89:1326-1330.
2. Kok Ying N, Ganesalingam M, Sabaratnam S. Cancer incidence in peninsular Malaysia. In National Cancer Registry, G Lim Chin Chye, S Rampal, and H Yahaya (eds.). Kuala Lumpur, Malaysia: National Cancer Registry, 2008, 1-286.
3. Cancer Statistics Branch, National Cancer Institute. Surveillance, Epidemiology and End Results. Available at: http://seer. cancer.gov/statfacts/
4. Ueda Y, Enomoto T, Egawa-Takata T,Miyatake T, Yoshino K, Fujita M,Matsuzaki S, Yokoyama T,Miyoshi Y, Kimura T. Endometrial carcinoma: better prognosis for asymptomatic recurrences than for symptomatic cases found by routine follow-up. Int J Clin Oncol 2008;15:406-412.
5. Doll A,Abal M, RigauM,Monge M,Gonzalez M,Demajo S, Coĺas E, Llaurad́o M, Alazzouzi H, Planaguḿa J, Lohmann MA, Garcia J, Castellvi S, Ramon y Cajal J, Gil-Moreno A, Xercavins J, Alameda F, Revent́os J. Novel molecular profiles of endometrial cancer - new light through old windows. J Steroid Biochem Mol Biol 2008;108:221-229. (Pubitemid 351179637)
6. Lilja JF, Wu D, Reynolds RK, Lin J. Growth suppression activity of the PTENtumor suppressor gene in human endometrial cancer cells. Anticancer Res 2001;21:1969-1974. (Pubitemid 32728938)
7. Zhu X, Kwon CH, Schlosshauer PW, Ellenson LH, Baker SJ. PTEN induces G(1) cell cycle arrest and decreases cyclin D3 levels in endometrial carcinoma cells. Cancer Res 2001;61:4569-4575. (Pubitemid 32685791)
8. Maxwell GL, Chandramouli GV, Dainty L, Litzi TJ, Berchuck A, Barrett JC, Risinger JI. Microarray analysis of endometrial carcinomas and mixed Mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer. Clin Cancer Res 2005;11:4056-4066. (Pubitemid 40791569)
9. Zhou C, Bae-Jump VL, Whang YE, Gehrig PA, Boggess JF. The PTEN tumor suppressor inhibits telomerase activity in endometrial cancer cells by decreasing hTERTmRNA levels. Gynecol Oncol 2006;101:305-310.
10. Kabbarah O, Mallon MA, Pfeifer JD, Goodfellow PJ. Transcriptional profiling endometrial carcinomas microdissected from DES-treated mice identifies changes in gene expression associated with estrogenic tumor promotion. Int J Cancer 2006;119:1843-1849. (Pubitemid 44356841)
11. Ferguson SE, Olshen AB, Viale A, Awtrey CS, Barakat RR, Boyd J. Gene expression profiling of tamoxifen-associated uterine cancers: Evidence for two molecular classes of endometrial carcinoma. Gynecol Oncol 2004;92:719-725. (Pubitemid 38183172)
12. Saghir FS, Rose IM, Dali AZ, Shamsuddin Z, Jamal AR, Mokhtar NM. Gene expression profiling and cancer-related pathways in type I endometrial carcinoma. Int J Gynecol Cancer 2010;20:724-731.
13. Draghici S,Khatri P, EklundAC, Szallasi Z. Reliability and reproducibility issues in DNAmicroarraymeasurements. Trends Genet 2006;22:101-109.
14. Esposito G. Complementary techniques: laser capture microdissection - increasing specificity of gene expression profiling of cancer specimens. Adv Exp Med Biol 2007;593:54-65
15. Ferguson SE, Olshen AB, Levine DA, Viale A, Barakat RR, Boyd J. Molecular profiling of endometrial cancers from African-American and Caucasian women. Gynecol Oncol 2006;101:209-213.
16. Wong YF, Cheung TH, Lo KW, Yim SF, Siu NSS, Chan SCS, Ho TWF,Wong KWY, Yu MY,Wang VW, Li C, Gardner GJ, Bonome T, Johnson WB, Smith DI, Chung TKH, and Birrer MJ. Identification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profiling. Oncogene 2007;26:1971-1982. (Pubitemid 46474633)
17. Du XL, Jiang T, Zhao WB, Wang F, Wang GL, Cui M, Wen ZQ. Gene alterations in tumor-associated endothelial cells from endometrial cancer. Int J Mol Med 2008;22:619-632.
18. McGrathM, Lee IM, Buring J, De Vivo I. Common genetic variation within IGFI, IGFII, IGFBP-1, and IGFBP-3 and endometrial cancer risk. Gynecol Oncol 2010;120:174-178.
19. Osawa A, Kato M, Matsumoto E, Iwase K, Sugimoto T, Matsui T, Ishikura H, Sugano S, Kurosawa H, Takiguchi M, Seki N. Activation of genes for growth factor and cytokine pathways late in chondrogenic differentiation of ATDC5 cells. Genomics 2006;88:52-64. (Pubitemid 43851177)
20. Wang Y, Ma Y, Lu B, Xu E, Huang Q, Lai M. Differential expression of mimecan and thioredoxin domain-containing protein 5 in colorectal adenoma and cancer: A proteomic study. Exp Biol Med (Maywood) 2007;232:1152-1159. (Pubitemid 47503056)
21. Lustig B, Jerchow B, Sachs M,Weiler S, Pietsch T, Karsten U, van de Wetering M, Clevers H, Schlag PM, Birchmeier W, Behrens J. Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Mol Cell Biol 2002;22:1184-1193. (Pubitemid 34094854)
22. Liu W, Dong X, Mai M, Seelan RS, Taniguchi K, Krishnadath KK, Halling KC, Cunningham JM, Boardman LA, Qian C, Christensen E, Schmidt SS, Roche PC, Smith DI, Thibodeau SN. Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling.NatGenet 2000;26:146-147.
23. Wu R, Zhai Y, Fearon ER, Cho KR. Diverse mechanisms of betacatenin deregulation in ovarian endometrioid adenocarcinomas. Cancer Res 2001;61:8247-8255. (Pubitemid 33091619)
24. Han HJ, Russo J, Kohwi Y, Kohwi-Shigematsu T. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 2008;452:187-193. (Pubitemid 351380252)
25. Patani N, Jiang W, Mansel R, Newbold R, Mokbel K.The mRNA expression of SATB1 and SATB2 in human breast cancer. Cancer Cell Int 2009;9:18.
26. Li QQ, Chen ZQ, Cao XX, Xu JD, Xu JW, Chen YY, Wang WJ, Chen Q, Tang F, Liu XP, Xu ZD. Involvement of NFkappaB/ miR-448 regulatory feedback loop in chemotherapyinduced epithelial-mesenchymal transition of breast cancer cells. Cell Death Differ 2011;18:16-25.
27. Fan X, Ross DD, Arakawa H, Ganapathy V, Tamai I, Nakanishi T. Impact of system L amino acid transporter 1 (LAT1) on proliferation of human ovarian cancer cells: A possible target for combination therapy with anti-proliferative aminopeptidase inhibitors. Biochem Pharmacol 2010;80:811-818.
28. Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, IshizukaT, Kanai Y, Endou H, Nakajima T, Mori M. Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in early stage squamous cell carcinoma of the lung. Cancer Sci 2008.
29. NawashiroH,Otani N,Uozumi Y,OoigawaH, Toyooka T, Suzuki T, Katoh H, Tsuzuki N, Ohnuki A, Shima K, Shinomiya N, Matsuo H, Kanai Y. High expression of L-type amino acid transporter 1 in infiltrating glioma cells. Brain Tumor Pathol 2005;22: 89-91. (Pubitemid 44576318)
30. Gielen SC, Hanekamp EE, Blok LJ, Huikeshoven FJ, Burger CW. Steroid-modulated proliferation of human endometrial carcinoma cell lines: Any role for insulin-like growth factor signaling? J Soc Gynecol Investig 2005;12:58-64. (Pubitemid 40039067)
31. Pavelic J, Radakovic B, Pavelic K. Insulin-like growth factor 2 and its receptors (IGF 1R and IGF 2R/mannose 6-phosphate) in endometrial adenocarcinoma. Gynecol Oncol 2007;105: 727-735. (Pubitemid 46734203)